首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma.
【24h】

Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma.

机译:染色体5q34上的等位基因缺失与肝细胞癌的不良预后有关。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To identify and characterize novel genetic alterations in hepatocellular carcinoma (HCC). METHODS: DNA was extracted from 29 HCC and corresponding normal tissues and amplified with 59 different 10-base arbitrary primers. A 550 bp DNA fragment amplified using primer Q-9 and which was present in 19 of 29 cases (66%) was cloned, sequenced, and compared with known nucleotide sequences deposited in Genome database, and quantified by real-time PCR. RESULTS: DNA alterations were found on chromosomes 5q34, 6p25.2 and 8q12.1 in 11 of 29 cases (38%), 7 of 29 cases (24%), and 12 of 29 cases (41%), respectively. Multivariate analysis showed that the allelic loss on chromosome 5q34 was an independent prognostic factor for poor survival of HCC patients, with the median survival time of 19 weeks for allelic loss versus 109 weeks for no allelic loss (P = 0.001). CONCLUSIONS: This study indicates that allelic loss on chromosome 5q34 may be involved in the development of HCC and could be used as a prognostic indicator in HCC patients.
机译:目的:鉴定和表征肝细胞癌(HCC)中的新基因改变。方法:从29个肝癌及相应的正常组织中提取DNA,并用59种不同的10碱基任意引物进行扩增。使用引物Q-9扩增了一个550 bp的DNA片段,该片段存在于29个病例中的19个(66%)中,进行了克隆,测序并与Genome数据库中保存的已知核苷酸序列进行了比较,并通过实时PCR进行了定量。结果:分别在29例中的11例(38%),29例中的7例(24%)和29例中的12例(41%)的5q34、6p25.2和8q12.1染色体上发现了DNA改变。多变量分析显示,染色体5q34上的等位基因缺失是肝癌患者不良生存的独立预后因素,等位基因缺失的中位生存时间为19周,无等位基因缺失的中位生存时间为109周(P = 0.001)。结论:这项研究表明5q34染色体上的等位基因缺失可能与肝癌的发生有关,可以作为肝癌患者的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号